Arthritis Drugs Archive | 2005

Arthritis Drugs

Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.


Arthritis Drugs - Issue: 18

Merck, Plaintiffs Have Different Ideas About Future of Calif. Cases

Read Full Article



Arthritis Drugs - Issue: 19

Merck Says 18-Month APPROVe Testimony Should be Heard

Read Full Article



Arthritis Drugs - Issue: 18

Judge: Learned Intermediary Doesn't Protect Sales Reps from Vioxx Claim

Read Full Article

Judge Orders Law Firms to Steer Clear of Jurors in Jersey Vioxx Case

Read Full Article

Jury Finds for Merck in New Jersey Vioxx Trial

Read Full Article



Arthritis Drugs - Issue: 17

Arthritis Drugs In the Medical Literature This Month

Read Full Article



Arthritis Drugs - Issue: 18

Sales Reps Improperly Joined to Celebrex Suit, Judge Rules

Read Full Article

State Vioxx Liaison Resigns to Form Plaintiffs' Counsel Coalition

Read Full Article




ISSUES BY YEAR




The HarrisMartin VerdicTrack



The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.